DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for Amyotrophic Lateral Sclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Amyotrophic Lateral Sclerosis and special features on late-stage and discontinued projects.
The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Amyotrophic Lateral Sclerosis Overview
- Therapeutics Development
- Pipeline Products for Amyotrophic Lateral Sclerosis - Overview
- Pipeline Products for Amyotrophic Lateral Sclerosis - Comparative Analysis
- Amyotrophic Lateral Sclerosis - Therapeutics under Development by Companies
- Amyotrophic Lateral Sclerosis - Therapeutics under Investigation by Universities/Institutes
- Amyotrophic Lateral Sclerosis Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Amyotrophic Lateral Sclerosis - Products under Development by Companies
- Amyotrophic Lateral Sclerosis - Products under Investigation by Universities/Institutes
- Amyotrophic Lateral Sclerosis - Companies Involved in Therapeutics Development
- 2-BBB Medicines BV
- AB Science SA
- Aestus Therapeutics, Inc.
- Anavex Life Sciences Corp.
- Angion Biomedica Corp.
- Apodemus AB
- Apogenix GmbH
- Apotex Inc.
- ArmaGen Inc.
- BioCrea GmbH
- Biogen, Inc.
- BrainStorm Cell Therapeutics Inc.
- CalAsia Pharmaceuticals, Inc.
- Calico LLC
- Catabasis Pharmaceuticals, Inc.
- Cellceutix Corporation
- Chronos Therapeutics Limited
- Cytokinetics, Inc.
- Daval International Limited
- Edison Pharmaceuticals, Inc.
- Eisai Co., Ltd.
- Evotec AG
- F. Hoffmann-La Roche Ltd.
- Flex Pharma, Inc.
- FPRT Bio Inc.
- Gemac
- Genentech, Inc.
- Genervon Biopharmaceuticals, LLC
- GeNeuro SA
- GenKyoTex S.A.
- Glialogix, Inc.
- Grifols, S.A.
- Herantis Pharma Plc
- ImStar Therapeutics Inc.
- IntelliCell BioSciences Inc.
For more information visit http://www.researchandmarkets.com/research/r8rhdt/amyotrophic
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
